These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10149537)

  • 1. Biocompatibility of extracorporeal immunoadsorption systems.
    Kadar JG; Borberg H
    Transfus Sci; 1990; 11(2):223-39. PubMed ID: 10149537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein A tangential flow affinity membrane cartridge for extracorporeal immunoadsorption therapy.
    Jia L; Yang L; Zou H; Zhang Y; Zhao J; Fan C; Sha L
    Biomed Chromatogr; 1999 Nov; 13(7):472-7. PubMed ID: 10534759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmapheresis and immunoadsorption: different techniques and their current role in medical therapy.
    Schneider KM
    Kidney Int Suppl; 1998 Feb; 64():S61-5. PubMed ID: 9475492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic immunoadsorption--its role in clinical practice.
    Braun N; Kadar JG; Risler T
    Transfus Sci; 1998 Mar; 19 Suppl():65-9. PubMed ID: 10178698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quo vadis haemapheresis. Current developments in haemapheresis.
    Borberg H
    Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical and clinical experience with protein A immunoadsorption columns.
    Belàk M; Borberg H; Jimenez C; Oette K
    Transfus Sci; 1994 Dec; 15(4):419-22. PubMed ID: 10155559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical use of immunosorption: problems and perspectives].
    Chuchalin AG; Lebedin IuS; Raudla LA
    Vestn Akad Med Nauk SSSR; 1990; (3):44-8. PubMed ID: 2191512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report.
    Sebastiani M; Puccini R; Manfredi A; Manni E; Colaci M; Mattei P; Barachini P; Ferri C
    Ther Apher Dial; 2009 Jun; 13(3):225-8. PubMed ID: 19527470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving tumor-to-normal-tissue ratios of antibodies by extracorporeal immunoadsorption based on the avidin-biotin concept: development of a new treatment strategy applied to monoclonal antibodies murine L6 and chimeric BR96.
    Tennvall J; Garkavij M; Chen J; Sjögren HO; Strand SE
    Cancer; 1997 Dec; 80(12 Suppl):2411-8. PubMed ID: 9406691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal immunoadsorption for the treatment of coagulation inhibitors.
    Franchini M; Sassi M; Dell'Anna P; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Targher G; Lippi G
    Semin Thromb Hemost; 2009 Feb; 35(1):76-80. PubMed ID: 19308895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical use of protein-A immunoadsorption].
    Aksenov VA
    Ter Arkh; 1996; 68(11):83-5. PubMed ID: 9045392
    [No Abstract]   [Full Text] [Related]  

  • 12. [Development of a technique of immunoadsorption of LDL-cholesterol].
    Regnault V; Rivat C; Schooneman F; Marcillier P; Michaely JP; Didelon J; Stoltz JF; Siadat M
    Ann Med Interne (Paris); 1990; 141(7):604-7. PubMed ID: 2085239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of autoimmune disease by immunomodulation through extracorporeal elimination and intravenous immunoglobulin.
    Borberg H; Jimenez C; Belàk M; Haupt WF; Späth P
    Transfus Sci; 1994 Dec; 15(4):409-18. PubMed ID: 10155558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new device for specific extracorporeal immunoadsorption of anti-DNA antibodies. In vitro and in vivo results.
    Traeger J; Laville M; Serres PF; Cronenberger M; Thomas M; Rey MJ; Bourgeat C
    Ann Med Interne (Paris); 1992; 143 Suppl 1():9-12. PubMed ID: 1300896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of demyelinating polyneuropathy with immunoadsorption, low dose corticosteroids and anti-CD20 monoclonal antibody.
    Rech J; Hueber AJ; Kallert S; Leipe J; Kalden JR; Beck M; Schett G; Schulze-Koops H
    Ther Apher Dial; 2008 Jun; 12(3):205-8. PubMed ID: 18503697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoadsorption therapy for myasthenia gravis: study on the adsorption capacity of an immunoadsorption column].
    Yeh JH; Chiu HC
    J Microbiol Immunol Infect; 1999 Jun; 32(2):121-5. PubMed ID: 11565565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membranes and polymer structures--biocompatibility aspects with respect to production limits.
    Ansorge W; Spindler E; Vienken J; Baurmeister U
    Transfus Sci; 1993 Apr; 14(2):199-209. PubMed ID: 10148613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of LDL-apheresis and immunoadsorption in kidney diseases.
    Sułowicz W; Stompór T
    Rocz Akad Med Bialymst; 2004; 49():127-34. PubMed ID: 15631328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased ethyl mercury load in protein a immunoadsorption.
    Marn-Pernat A; Buturović-Ponikvar J; Logar M; Horvat M; Ponikvar R
    Ther Apher Dial; 2005 Jun; 9(3):254-7. PubMed ID: 15967001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis-immunoadsorption for treatment of systemic lupus erythematosus in a dog.
    Matus RE; Scott RC; Saal S; Gordon BR; Hurvitz AI
    J Am Vet Med Assoc; 1983 Mar; 182(5):499-502. PubMed ID: 6339455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.